Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature

Transplantation

Volumn 77, Issue 2, 2004, Pages 311-313

  Camós, Mireia ^a   Esteve, Jordi ^a   Rimola, Antoni ^a   Grande, Luis ^a   Rozman, María ^a   Colomer, Dolors ^a   Villamor, Neus ^a   Costa, Dolors ^a   Montserrat, Emili ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER INCIDENCE; EPSTEIN BARR VIRUS; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REMISSION; STANDARDIZATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKEMIA, MYELOCYTIC, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0742304544     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000102549.40531.13     Document Type: Article

References (11)

1. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12: 328-336.
2. Thalhammer-Scherrer R, Wieselthales G, Knoebl P, et al. Post-transplant acute myeloid leukemia (PT-AML). Leukemia 1999; 13: 321-326.
3. Huebner G, Karhaus M, Pethig K, et al. Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation. Transplantation 2000; 70: 688-690.
4. Bodo I, Peters M, Radich J, et al. Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med 1999; 341: 807-813.
5. Doti CA, Gondolesi GE, Sheiner PA, et al. Leukemia after liver transplant. Transplantation 2001; 72: 1643-1646.
6. Saigal S, Norris S, Muiesan P, et al. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482-487.
7. Ries LG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1973-1977. Bethesda, MD, National Cancer Institute 2000.
8. McNally RJQ, Rowland D, Roman E, et al. Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 1997; 15: 173-189.
9. Sutton L, Guénel P, Tanguy ML, et al. Acute myeloid leukemia in human immunodeficiency virus-infected adults: Epidemiology, treatment feasibility and outcome. French Study Group on Acute Myeloid Leukemia in HIV-Infected Patients. Br J Haematol 2001; 112: 900-908.
10. Kanegane H, Nomura K, Miyawaki T, et al. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol 2002; 44: 239-249.
11. Pollicardo N, O'Brien S, Estey EH, et al. Secondary acute promyelocytic leukemia: Characteristics and prognosis of 14 patients from a single institution. Leukemia 1996; 10: 27-31.